DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Dhoot Transmission Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·13 Oct 2026, 12:26 pm

Dhoot Transmission

Dhoot Transmission Limited has informed stock exchanges that it has received a certificate under the SEBI (Depositories and Participants) Regulations, 2018. This regulatory compliance document confirms that the company has fulfilled the necessary requirements to operate as a Depository Participant (DP).

For investors, this development is a procedural milestone rather than a financial event. It indicates that Dhoot Transmission has successfully met the regulatory standards set by the Securities and Exchange Board of India (SEBI) to manage dematerialized securities. This status is essential for the company's core business operations involving share transfers and settlements.

Investors should view this as a standard administrative update. It does not signal a change in the company's financial performance or business strategy. Moving forward, the focus should remain on the company's operational metrics and market performance rather than this regulatory filing.